COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome-the superantigen hypothesis.

J Allergy Clin Immunol

Division of Pediatric Infectious Diseases and Immunology, Department of Biomedical Sciences, Infectious and Immunologic Diseases Research Center, Cedars-Sinai Medical Center, Los Angeles, Calif; Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, Calif; Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, Calif. Electronic address:

Published: January 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564502PMC
http://dx.doi.org/10.1016/j.jaci.2020.10.008DOI Listing

Publication Analysis

Top Keywords

covid-19-associated multisystem
4
multisystem inflammatory
4
inflammatory syndrome
4
syndrome children
4
children mis-c
4
mis-c a novel
4
a novel disease
4
disease mimics
4
mimics toxic
4
toxic shock
4

Similar Publications

Article Synopsis
  • The CAMP study is an ongoing research project aiming to assess the mid- and long-term effects of myocarditis and pericarditis following the Pfizer-BioNTech COVID-19 vaccine in patients under 21.
  • It involves a cohort of at least 200 vaccinated patients and a comparison group of 100 patients with COVID-19 related myocarditis, collecting data over a 5-year span to track health outcomes and complications.
  • As of October 16, 2024, the study has enrolled 273 participants, focusing on heart function, complications, and overall quality of life post-illness.
View Article and Find Full Text PDF
Article Synopsis
  • COVID-19 can lead to multiorgan issues, including thrombotic microangiopathy (TMA), which we studied in eight patients at our center.
  • Most patients showed few COVID-19 symptoms, and TMA occurred after the virus was present in their system; two had additional non-COVID-related factors triggering TMA.
  • Treatments varied based on the type of TMA, with some achieving recovery in blood and kidney functions, highlighting the need for tailored treatment approaches due to different causes and responses.
View Article and Find Full Text PDF

Objectives: Neurological manifestations of Severe Acute Respiratory Syndrome coronavirus-2 have been well documented in adults during and after infection with the virus as well as after vaccination. The incidence of severe neurological symptoms among children is very low. This study aimed to analyze the varied neurological manifestations after COVID-19 infection among children and give a report on a single-center experience with these severe neurological symptoms.

View Article and Find Full Text PDF

COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) is a rare autoimmune disorder characterized by a range of polymorphic manifestations, similar to but distinct from other well-known inflammatory syndromes in children. We conducted a retrospective-descriptive study in which we summarized the clinical presentation of, biomarker variations in, and complications occurring in patients diagnosed with MIS-C, admitted to the Emergency Clinical Hospital for Children "Sf. Ioan", Galati, between July 2020 and June 2024.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the variation of COVID-19-associated multisystem inflammatory syndrome (MIS-C) in Peru during the first three years of the pandemic, highlighting a decrease in cases over time.
  • During the second wave, MIS-C was more prevalent, exhibiting symptoms similar to Kawasaki disease, with a significant portion of patients experiencing gastrointestinal and mucocutaneous issues.
  • The findings suggest that while MIS-C cases decreased mainly due to vaccination efforts, healthcare providers need to remain vigilant in diagnosing MIS-C in unvaccinated children weeks after peak COVID-19 infection periods.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!